摘要
目的:探讨阿奇霉素治疗社区获得性肺炎的临床效果和安全性。方法:将100例患者随机分成观察组和对照组各50例,两组在对症治疗的基础上,观察组应用阿奇霉素,对照组应用头孢呋辛,观察两组的临床治疗效果和不良反应。结果:观察组总有效率为96.00%,明显高于对照组的78.00%,二者差异存在统计学意义(P<0.05);观察组不良反应发生率为12.00%,对照组为10.00%,二者比较差异无统计学意义(P>0.05)。结论:阿奇霉素治疗社区获得性肺炎,临床有效率高,不良反应少,安全有效。
Objective：To discuss treatment efficacy and safety of azithromycin for community acquired pneumonia.Methods：100 patients were divided randomly into observation group（50 eases） and control group（50 cases）.On the basis of symptomatic treatment,the observation group was treated with azithromycin,and the control group was treated with cefuroxime.Then clinical effect and adverse events in each group were observed.Results：Total effective rate of the observation group （96.00%）was higher than that of the control group （7800%）,and the difference was statistically significant（P005）;Adverse reaction rate is 12.00% in observation group,and 1000% in control group,there is no significant difference（P005）.Conclusion：Azithromycin is worthy of clinical application to treat community acquired pneumonia because it possesses the advantages of high clinical effects and safty,less adverse events.
